Immunogenicity and Safety of vYF, a Yellow Fever Vaccine - A Phase 2 Trial.

Feroldi E, Mulligan MJ, Talaat KR, Tan CS, Paolino K, Edupuganti S, Collins MH, George SL, Davis M, Essink B, Jeanfreau R, Peterson J, Fried D, Minutello AM, Orlando S, Korejwo J, Rojas A, Dufournet M, Machabert T, Devlin L, Frago C, vYF Vaccine Study Team

Open source

DOI: 10.1056/nejmoa2505665
Published: 2026 Apr 9
Container: The New England journal of medicine
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa2505665,
  title = {Immunogenicity and Safety of vYF, a Yellow Fever Vaccine - A Phase 2 Trial.},
  author = {Feroldi E and Mulligan MJ and Talaat KR and Tan CS and Paolino K and Edupuganti S and Collins MH and George SL and Davis M and Essink B and Jeanfreau R and Peterson J and Fried D and Minutello AM and Orlando S and Korejwo J and Rojas A and Dufournet M and Machabert T and Devlin L and Frago C and vYF Vaccine Study Team},
  year = {2026},
  journal = {The New England journal of medicine},
  doi = {10.1056/nejmoa2505665},
  url = {https://doi.org/10.1056/nejmoa2505665}
}

RIS

TY  - JOUR
TI  - Immunogenicity and Safety of vYF, a Yellow Fever Vaccine - A Phase 2 Trial.
AU  - Feroldi E
AU  - Mulligan MJ
AU  - Talaat KR
AU  - Tan CS
AU  - Paolino K
AU  - Edupuganti S
AU  - Collins MH
AU  - George SL
AU  - Davis M
AU  - Essink B
AU  - Jeanfreau R
AU  - Peterson J
AU  - Fried D
AU  - Minutello AM
AU  - Orlando S
AU  - Korejwo J
AU  - Rojas A
AU  - Dufournet M
AU  - Machabert T
AU  - Devlin L
AU  - Frago C
AU  - vYF Vaccine Study Team
PY  - 2026
JO  - The New England journal of medicine
DO  - 10.1056/nejmoa2505665
UR  - https://doi.org/10.1056/nejmoa2505665
ER  -

APA

E, F., MJ, M., KR, T., CS, T., K, P., S, E., MH, C., SL, G., M, D., B, E., R, J., J, P., D, F., AM, M., S, O., J, K., A, R., M, D., T, M., L, D., C, F., & Team, V. V. S. (2026). Immunogenicity and Safety of vYF, a Yellow Fever Vaccine - A Phase 2 Trial.. The New England journal of medicine. https://doi.org/10.1056/nejmoa2505665

Source records

pubmed · retrieved 2026-09-26T05:06:15.026Z